Cambrooke Therapeutics closes Series C round, led by Seventure
Cambrooke Therapeutics Inc., the Ayers, Massachusetts, provider of medical nutrition products, closed a Series C investment round, led by Seventure Partners, the Paris asset manager. Seventure invested out of its Health For Life Capital vehicle, Cambrooke said in a statement. Also participating: Galen Partners, the Stamford, Connecticut, venture-capital firm and other co-investors from Europe and the United States. Oxana Kukhaneva, a partner at Seventure, has joined Cambrooke’s board.
11 April 2016•2 mins read
